Prospective study of short-term peginterferon-α-2a monotherapy in patients who had a virological response at 2 weeks after initiation of interferon therapy-Reference-Cited by-同舟云学术

Prospective study of short-term peginterferon-α-2a monotherapy in patients who had a virological response at 2 weeks after initiation of interferon therapy

Published:2008-04 Issue:4 Volume:23 Page:541-545
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Jeong Soocheol,Kawakami Yoshiiku,Kitamoto Mikiya,Ishihara Hiroto,Tsuji Keiji,Aimitsu Shiomi,Kawakami Hiroiku,Uka Kiminori,Takaki Shintaro,Kodama Hideaki,Waki Koji,Imamura Michio,Aikata Hiroshi,Takahashi Shoichi,Chayama Kazuaki

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2008.05356.x/fullpdf

Reference31 articles.

1. Epidemiology of Hepatitis C in the West

2. Natural history of liver fibrosis progression in patients with chronic hepatitis C

3. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus

4. Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First Week HCV RNA Level Under the Pegylated Interferon and Ribavirin Treatment Predicts Sustained Virological Response;American Journal of Therapeutics;2016-11

2. Low-dose pegylated interferon-alpha-2a monotherapy in elderly and/or cirrhotic patients infected with hepatitis C virus genotype-2 or genotype-1 low level infection;Hepatology Research;2012-12-17

3. Response-guided therapy based on reaction to the initial dose using administration of peginterferon α-2a alone or in combination with ribavirin in naïve patients with chronic hepatitis C of serotype 2 and high viral loads;Kanzo;2012

4. Factors affecting efficacy of pegylated interferon alpha-2a in chronic hepatitis C patients with serotype 2;Kanzo;2011

5. Nueva formulación liofilizada sin albúmina de interferón alfa-2b en pacientes con condiloma acuminado;Piel;2009-07